ASX
Andrew Forrest backs ASX-listed psychedelic drugs medtech Emyria with $5m and its shares popped
Shares in alternative drugs development company Emyria (ASX: EMD) popped 20% today on news that mining billionaire Dr Andrew Forrest’s family investment firm, Tattarang, had invested $5 million via a share placement. Emyria (ASX: EMD) shares closed at $0.39 cents following Monday’s trade after news of Tattarang becoming a strategic investor at $0.25 cents a… Read more »
